If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.
Experts are hoping that, by imaging the dinosaur’s shoulder girdle and forelimb, they can create a digital model that could help in determining a T. Rex arm’s range of motion and strength.
Claustrophobic or not, most would choose the radiation-free modality over CT and tend to consider imaging-exam outcomes more worrisome than MRI in and of itself anyway.
A new brain imaging study is giving experts insight into how medication used to treat ADHD works in the brain to soften symptoms associated with the neurological disorder.
New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.
Common markers of Alzheimer's disease visualized on PET scans of asymptomatic patients might foreshadow the onset of symptoms in the years following their initial discovery.
Researchers have completed a new analysis of the Evolut Pro and Pro+ devices from Medtronic and the Sapien 3 Ultra devices from Edwards Lifesciences, sharing the results in JACC: Cardiovascular Interventions.
